Detail (Long)
<b>Booster doses (≥12 yo):</b> 1 dose (30 μg) ≥5mo after primary series (may give heterologous booster doses if 18 yo and older, but eligibility criteria and dosing interval should follow primary series product); if moderately-severely immunocompromised, give 3mo after primary series; in pts ≥50 yo or moderately-severely immunocompromised pts, give 2nd dose (30 μg) >4mo after 1st dose